# New Animal Drugs; Meloxicam
> **Food and Drug Administration** · Final rule. · Published 2004-11-30 · Effective 2004-11-30 · 69 FR 69523
## Document
- **Document number:** 04-26380
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 69 FR 69523
- **CFR reference:** 21 CFR 520
- **Publication date:** 2004-11-30
- **Effective date:** 2004-11-30
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Boehringer Ingelheim Vetmedica, Inc. The first supplemental NADA provides for use of meloxicam injectable solution in cats for control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. It also provides revised dosage labeling for this product in dogs. The other supplemental NADA provides revised dosage labeling for use of meloxicam oral suspension in dogs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2004/11/30/04-26380/new-animal-drugs-meloxicam)
---
*AI Analytics · CC0 1.0*